ImmunologyScience AdvancesPeer-reviewed
CD4+Foxp3E2+ regulatory T cell frequency predicts breast cancer prognosis and recurrence
Clorinda Fusco, Francesca Di Rella, Antonietta Liotti…·Veronica De Rosa
The paper identifies Foxp3E2+ regulatory T cells as a prognostic biomarker for breast cancer recurrence and immune suppression.
13 citationstop 5%